91影库

News

Tardigrades: Surviving extreme radiation

Chaitra Shree Udugere Shivakumara Swamy Thomas C. Boothby
By Chaitra Shree Udugere Shivakumara Swamy and Thomas C. Boothby
Aug. 11, 2024

When you think about the toughest animal in the world, you might think of a lion or tiger. But a less well-known contender for this title is a tiny animal known as a tardigrade, which is renowned for surviving extreme conditions. This includes being frozen, heated past the boiling point of water, completely dried out, exposed to the vacuum of outer space, and even being bombarded with extremely high levels of ionizing radiation (; ).

How tardigrades endure these extremes is one of the prevailing mysteries of physiology. Now, in eLife, Jean-Paul Concordet and Anne de Cian from the Mus茅um National d'Histoire Naturelle and colleagues – including Marwan Anoud, Emmanuelle Delagoutte and Quentin Helleu as joint first authors – report new insights into how tardigrades survive exposure to ionizing radiation ().

Ionizing radiation typically damages cells by causing their DNA to fragment (). In the past, it was thought that organisms capable of surviving extreme doses of radiation, like tardigrades, might do so by blocking and preventing the radiation from harming their DNA. A previous report suggests that tardigrades utilize a protein known as Dsup to prevent DNA damage during radiation exposure (). However, Anoud et al. found that tardigrades accumulate the same amount of DNA damage as organisms and cells which are intolerant to radiation, such as human cells grown in a dish (). If tardigrades do not survive ionizing radiation by directly blocking DNA damage, how do they endure such an insult?

To investigate, the team (who are based at various institutes in France and Italy) examined three species of tardigrade, using a technique known as RNA sequencing, to see which genes are switched on when exposed to ionizing radiation. They also tested tardigrades exposed to bleomycin – a drug that mimics the effects of radiation by creating double-stranded breaks in DNA.

Anoud et al. found that tardigrades upregulated the expression of genes involved in the DNA repair machinery that is common across many life forms, ranging from single-celled organisms to humans. The DNA damage the tardigrades initially accumulated following radiation or treatment with bleomycin also gradually disappeared after the exposure. Overall, these results strongly suggest that to cope with the DNA damage caused by ionizing radiation, tardigrades mount a robust set of repair mechanisms to help stitch their shattered genome back together.

In addition to seeing that DNA repair machinery is upregulated following ionizing radiation, Anoud et al. identified a new gene only present in tardigrades, which encodes a protein they named TDR1 (short for tardigrade DNA repair protein 1). Further experiments revealed that TDR1 can enter the cell nucleus and bind to DNA. This may be due to conserved portions of TDR1, which are largely positively charged, electrostatically interacting with negatively charged DNA. Moreover, at high concentrations, TDR1 not only binds to DNA, but forms aggregates in a concentration-dependent manner. Finally, Anoud et al. found that introducing the gene for TDR1 into healthy human cells reduced the amount of DNA damage caused by bleomycin, indicating that the TDR1 protein helps with DNA repair ().

Expressing the tardigrade protein TDR1 in human cells increases DNA damage repair.

(A) In tardigrades, exposure to ionizing radiation or the drug bleomycin leads to DNA damage, such as double-stranded breaks (circle inset). This switches on various genes (triangles) that repair the genome, including the gene that codes for a protein called TDR1 (red triangle). (B) Bleomycin treatment (represented as lightning bolts) also causes double-stranded DNA breaks in human cells. However, these cannot be efficiently repaired, resulting in cell death. (C) Anoud et al. found that introducing the gene for TDR1 to the genome of human cells increases their ability to repair DNA damage and their chance of survival.
BioRender Inc. Figure 1 was created using BioRender, and is published under a CC BY-NC-ND license. Further reproductions must adhere to the terms of this license.
(A) In tardigrades, exposure to ionizing radiation or the drug bleomycin leads to DNA damage, such as double-stranded breaks (circle inset). This switches on various genes (triangles) that repair the genome, including the gene that codes for a protein called TDR1 (red triangle). (B) Bleomycin treatment (represented as lightning bolts) also causes double-stranded DNA breaks in human cells. However, these cannot be efficiently repaired, resulting in cell death. (C) Anoud et al. found that introducing the gene for TDR1 to the genome of human cells increases their ability to repair DNA damage and their chance of survival.

While it is still unclear exactly how tardigrades fix DNA damage, this study suggests that their ability to survive extreme radiation is related to their strong DNA repair ability, which TDR1 likely plays a crucial role in. Anoud et al. found that TDR1 did not accumulate at DNA damage sites like some other repair proteins (). Instead, they propose that the protein mends DNA by binding to it and forming aggregates which compact the fragmented DNA and help maintain the organization of the damaged genome.

However, more research is needed to fully understand the mechanism responsible for TDR1 and other proteins helping tardigrades to survive ionizing radiation. Ultimately, knowing how these tiny organisms efficiently repair their DNA could lead to novel strategies for protecting human cells from radiation damage, which could benefit cancer treatment and space exploration.

This article is republished from . Read the original.

Enjoy reading 91影库Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Chaitra Shree Udugere Shivakumara Swamy
Chaitra Shree Udugere Shivakumara Swamy

Chaitra Shree Udugere Shivakumara Swamy is a graduate student in molecular biology at the University of Wyoming, Laramie.

Thomas C. Boothby
Thomas C. Boothby

Thomas C. Boothby is an assistant professor of molecular biology at the University of Wyoming, Laramie.

Get the latest from 91影库Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Feature

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

Defeating deletions and duplications
News

Defeating deletions and duplications

July 11, 2025

Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader鈥揥illi syndrome.

Using 'nature鈥檚 mistakes' as a window into Lafora disease
Feature

Using 'nature鈥檚 mistakes' as a window into Lafora disease

July 10, 2025

After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer鈥檚 code through functional connections
News

Cracking cancer鈥檚 code through functional connections

July 2, 2025

A machine learning鈥揹erived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.

Gaze into the proteomics crystal ball
In-person Conference

Gaze into the proteomics crystal ball

July 1, 2025

The 15th International Symposium on Proteomics in the Life Sciences symposium will be held August 17鈥21 in Cambridge, Massachusetts.